The Wyatt Foundation and The Conceive Fertility Foundation Announce Launch of 2025 IVF Grant Program | COO Stock News

Author's Avatar
3 days ago
Article's Main Image
  • CooperSurgical (COO, Financial) partners with The Wyatt Foundation and The Conceive Fertility Foundation for the 2025 IVF Grant Program.
  • The program will offer $15,000 grants to five recipients, plus an additional $1,000 from CooperSurgical for preimplantation genetic testing (PGT).
  • Applications open from April 21 to June 23, 2025, with recipients announced on July 1, 2025.

The Wyatt Foundation and The Conceive Fertility Foundation, in partnership with CooperSurgical (COO), have announced the launch of their 2025 IVF grant program. The initiative, launched during National Infertility Awareness Week (April 20-26, 2025), aims to provide $15,000 grants to five individuals or couples in need of in vitro fertilization (IVF) to build their families. CooperSurgical will contribute an additional $1,000 per recipient specifically for preimplantation genetic testing (PGT) with ICSI.

The program intends to alleviate financial barriers faced by many seeking fertility care. Interested applicants can apply between April 21 and June 23, 2025, and must demonstrate financial need and a formal infertility diagnosis to qualify. The winners will be announced on July 1, 2025.

A key feature of the program is that recipients choosing a clinic within The Prelude Network will receive a 10% discount on fertility services, helping to further ease the financial burden of treatment.

CooperSurgical, a leader in the fertility and women's health sector for nearly 35 years, is excited to join this initiative, highlighting its commitment to supporting those on their journey to parenthood. "We are honored to be able to support The Wyatt Foundation's and The Conceive Foundation's IVF grant program as part of our ongoing commitment to empowering the journey to parenthood," said Holly Sheffield, President of CooperSurgical.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.